Healthcare in the Decade Ahead:
 HealthCast: The Customization of Diagnosis, Care & Cure

• Change Drivers: Chronic disease; Digitization; & Convergence of behavioral, socio-economic and genetic factors
• Six key areas around which health systems will incorporate customization for patient-centered care
• Examples of new health delivery models in the future and touch points of care that are customized
• Specific recommendations to build towards a patient-centered model of care customized to individuals
• Based on in-depth global research from PricewaterhouseCoopers Health Research Institute

The main thesis is that care, in the future, will be customized to individuals as performance metrics, payment, outcomes, incentives, services and treatments address differences in their needs and preferences and as the focus of health systems shifts from reactive medicine to prevention and cure. This thesis is based on a year-long study by PricewaterhouseCoopers Health Research Institute, including interviews with 200 health leaders in 25 countries around the world.

The session will include four sections:

1. In-depth examination of three predominant drivers of the change: 1) Chronic diseases, 2) Digitization: 3) A broader view of the converged health influences of behavioral, socio-economic and genetic factors that are not within the control of today’s medical delivery system.
2. Exploration six key areas around which health systems are likely to incorporate customization as they build a system of patient-centered care. These areas include incentive based payment, funding mechanisms, patient communication, workforce, broad-based regulatory reforms and electronic medical records.
3. Examples of new health delivery models in the future and touch points of care that are customized.
4. Specific recommendations for health leaders as they work toward a patient-centered model of care customized to individuals.

Observations and recommendations will be tailored to the needs of healthcare stakeholders who have the responsibility of guiding health systems and organizational growth and adaptation. The presentation will cut across all health segments—health systems, physicians, insurers, pharmaceutical companies, medical devices and life sciences and will present a blueprint for change that session participants can incorporate into their respective planning processes. The discussion will examine policy and societal changes, scientific development, technology and cultural expectations.

The basis of this presentation rests on the data and analysis laid out in a paper published by PricewaterhouseCoopers’ Health Research Institute, entitled HealthCast: The Customization of Diagnosis, Care and Cure. The report reflects proprietary research conducted by PwC, including more than 200 in-depth interviews in 25 countries with thought leaders and executives representing government, hospitals, pharmaceutical companies, insurance companies, clinicians, academics and the business community and a survey of 3,500 individuals in seven countries and 590 leaders of health plans, providers, government, employers, physician groups and pharmaceutical/life science firms in 20 countries.

• In-depth review of the various scientific and technological advancements that will enable “mass customization in healthcare”.
• How communication and education are the key variables that will alter every aspect of the healthcare business--from patient-physician relationship to drug development to new services, and the opportunity they represent for non-traditional, new entrants to the field of healthcare.
• How funding methodologies will change in order to better meet the goal of more efficient, personalized care by including incentives that better align with best practices.
• How the patient will emerge as the primary driver in the management of their own chronic care.
• Most effective strategies for engaging patients proactively in managing their health.
• The language of a re-imagined health delivery system—definitions and descriptions of coordinated care teams, patient experience benchmarks, care-anywhere networks, fluent navigators and medical proving grounds.
• Definition of terms
   

• C-Suite Executives
• Strategy, Planning and Policy Executives and Staff
• Medical Directors
• Clinical Executives
• Business Development Executives
• Business, Clinical and Market Intelligence Staff
• Other Interested Parties

Attendees would represent organizations including:

• Hospitals
• Provider Networks
• Medical Groups
• Health Plans and Insurance Companies
• Pharmaceutical Organizations and PBMs
• Medical Device Companies
• Care Management Organizations
• Health Technology Companies
• Solutions Providers
• Associations, Institutes and Research Organizations
• Media and other Interested Organizations